Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 5, 2012, Pages 547-549

  Bakri, Sophie J ^a   Omar, Ahmed F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BRIMONIDINE; DEXAMETHASONE;

AGED; ANEMIA; ARTICLE; BLURRED VISION; CASE REPORT; CATARACT; CATARACT EXTRACTION; CENTRAL RETINA VEIN OCCLUSION; DIABETES MELLITUS; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; INTRAVITREAL IMPLANT; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA EDEMA; RETINA MACULA HEMORRHAGE; RETINA MACULOPATHY; RHEUMATOID ARTHRITIS; SUBRETINAL FLUID; VISUAL ACUITY; VITREOMACULAR TRACTION; VITREOUS BODY DETACHMENT; VITREOUS DISEASE;

AGED; DEXAMETHASONE; DRUG IMPLANTS; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; RETINAL VEIN; RETINAL VEIN OCCLUSION; SYNDROME; TOMOGRAPHY, OPTICAL COHERENCE; VITREOUS BODY;

EID: 84866985056     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0184     Document Type: Article

References (17)

1. Haller, J., Bandello, F., Belfort, R., et al. Novel dexamethasone drug delivery system in treatment of RVO. Ophthalmology 117:1134-1146, 2010.
2. Haller, J., Bandello, F., Belfort, R., et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 118:2453-2460, 2011.
3. Rehak, J., and Rehak, M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr. Eye Res. 33:111-131, 2008.
4. SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6. Arch. Ophthalmol. 127: 1115-1128, 2009.
5. Campochiaro, P.A., Hafiz, G., Shah, S.M., et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol. Ther. 16:791-799, 2008.
6. Brown, D.M., Campochiaro, P.A., Singh, R.P., et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117:1124-1133, 2010.
7. Campochiaro, P.A., Heier, J.S., Feiner, L., et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117:1102-1112, 2010.
8. SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5. Arch. Ophthalmol. 127:1101-1114, 2009.
9. Ramezani, A., Entezari, M., Moradian, S., et al. Intravitreal triamcinolone for acute central retinal vein occlusion: a randomized clinical trial. Graefes Arch. Clin. Exp. Ophthalmol. 244:1601-1606, 2006.
10. Jaffe, N.S. Vitreous traction at the posterior pole of the fundus due to alternations in the vitreous posterior. Trans. Am. Acad. Ophthalmol. Otolaryngol. 71:642-652, 1967.
11. Koizumi, R., Spaide, R.F., Fisher, Y.L., Freund, K.B., Klancnik Jr., J.M., and Yannuzzi, L.A. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am. J. Ophthalmol. 145:509-517, 2008.
12. Chang, L.K., Fine, H.F., Spaide, R.F., Koizumi, H., and Grossniklaus, H.E. Ultrastructural correlation of spectral-domain optical coherence tomography findings in vitreomacular traction syndrome. Am. J. Ophthalmol. 146:121-127, 2008.
13. Gandorfer, A., Rohleder, M., and Kampik, A. Epiretinal pathology of vitreomacular traction syndrome. Br. J. Ophthalmol. 86:902-909, 2002.
14. Bhagat, N., Goldberg, M.F., and Gascon, P., et al. Central retinal vein occlusion: report of two familial cases. Eur. J. Ophthalmol. 9:181-195, 1999.
15. Spaide, R.F., Chang, L.K., Klancnik, J.M., Yannuzzi, L.A., Sorenson, J., Slakter, J.S., Freund, K.B., and Klein, R. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am. J. Ophthalmol. 147:298-306, 2009.
16. Odrobina, D., Michalewska, Z., Michalewski, J., Dziegielewski, K., and Nawrocki, J. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography. Retina 31:324-331, 2011.
17. Hikichi, T., Yoshida, A., and Trempe, C.L. Course of vitreomacular traction syndrome. Am. J. Ophthalmol. 119: 55-61, 1995.